AAAAAA
Results:
1-7
|
Results: 7
Authors:
Toydemir, PB
Elhan, AH
Tukun, A
Toydemir, R
Gurler, A
Tuzuner, A
Bokesoy, I
Citation: Pb. Toydemir et al., Assessment of prothrombotic risk in patients with Behcet's disease should include homocysteine plasma levels - Reply, J RHEUMATOL, 28(12), 2001, pp. 2765-2765
Authors:
Demirer, S
Sengul, N
Yerdel, MA
Tuzuner, A
Ulus, AT
Gurler, A
Bergqvist, D
Siegbahn, A
Karacagil, S
Citation: S. Demirer et al., Haemostasis in patients with Behcet's disease, EUR J VAS E, 19(6), 2000, pp. 570-574
Authors:
Boyvat, A
Sisman-Solak, C
Gurler, A
Citation: A. Boyvat et al., Long-term effects of interferon alpha 2A treatment in Behcet's disease, DERMATOLOGY, 201(1), 2000, pp. 40-43
Authors:
Sengul, N
Demirer, S
Yerdel, MA
Terzioglu, G
Akin, B
Gurler, A
Tuzuner, A
Citation: N. Sengul et al., Comparison of coagulation parameters for healthy subjects and Behcet disease patients with and without vascular involvement, WORLD J SUR, 24(12), 2000, pp. 1584-1588
Authors:
Toydemir, PB
Elhan, AH
Tukun, A
Toydemir, R
Gurler, A
Tuzuner, A
Bokesoy, I
Citation: Pb. Toydemir et al., Effects of factor V gene G1691A, methylenetetrahydrofolate reductase gene C677T, and prothrombin gene G20210A mutations on deep venous thrombogenesisin Behcet's disease, J RHEUMATOL, 27(12), 2000, pp. 2849-2854
Authors:
Kucuk, O
Aras, G
Soylu, A
Gurler, A
Tulunay, O
Ormeci, N
Duzgun, N
Bengi, N
Ibis, E
Akin, A
Citation: O. Kucuk et al., Evaluation of gastrointestinal involvement of Behcet's disease by nuclear medical techniques, ANN NUCL M, 13(4), 1999, pp. 211-214
Authors:
Anadolu, R
Boyvat, A
Calikoglu, E
Gurler, A
Citation: R. Anadolu et al., Buschke-Loewenstein tumour is not a low-grade carcinoma but a giant verruca, ACT DER-VEN, 79(3), 1999, pp. 253-254
Risultati:
1-7
|